New trials show promise for immune checkpoint blockers in early-stage lung cancer

A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).

Related Keywords

Belgium ,Photobytawat Shutterstock , ,Cell Reports Medicine ,